Global Vitamin API Market to grow significantly owing to new product development and approvals

Comments ยท 26 Views

The Global Vitamin API Market Demand is estimated to be valued at US$ 451.1 MN in 2024 and is expected to exhibit a CAGR of 6.1% over the forecast period 2024 to 2031.

The Global Vitamin API Market refers to active pharmaceutical ingredients used to manufacture vitamin drugs and supplements. Vitamin APIs help maintain health and reduce the risk of certain diseases by supporting critical metabolic functions. Demand for vitamin APIs has increased substantially as more vitamin supplements are developed and consumed globally. Calcium, Vitamin D, Vitamin B, and multivitamin APIs are some of the widely used types. Manufacturers utilize vitamin APIs to produce diverse consumer and prescription products including tablets, capsules, oral liquid solutions etc. The convenience and perceived health benefits of vitamin supplements have boosted their uptake worldwide in recent times.

The Global Vitamin API Market Demand is estimated to be valued at US$ 451.1 MN in 2024 and is expected to exhibit a CAGR of 6.1% over the forecast period 2024 to 2031.

Key Takeaways
Key players operating in the Global Vitamin API Market are DSM, BASF, BOC Sciences, CSPC Pharmaceutical Group Limited, Lonza, Zhejiang Medicine, Jubilant Life Sciences, Glanbia Nutritionals, Aurorium, Northeast Pharmaceutical Group Co., Ltd, Abbott Laboratories and Fermenta Biotech Ltd.
The growing consumer awareness about preventive healthcare and the necessity of maintaining healthy vitamin levels through dietary supplements presents significant opportunities for API manufacturers. Vitamin supplements are increasingly adopted as alternatives to prescriptions in treating deficiencies and supporting immunity.
Technological advancements in microencapsulation and nanotechnology have enabled the development of innovative delivery systems for vitamin APIs. This ensures better absorption, stability and bioavailability of vitamins. New formulations such as sustained and extended release APIs are expanding the applications of vitamins.

Market drivers
The rising geriatric population globally is a major market driver as older adults are more susceptible to vitamin deficiencies. According to estimates, over 700 million people will be aged 65 years and above by 2025. This demographic segment relies more on supplements for their daily nutritional needs. Increased per capita healthcare expenditure on preventive care in emerging economies is also fueling the adoption of vitamin supplements. The quest for cost-effective and efficient healthcare alternatives would continue supporting the uptake of vitamin APIs in developing regions over the forecast period.


Current Challenges in Global Vitamin API Market
The global vitamin API market has been witnessing rising demand on account of growing health awareness among people globally. However, this market also face certain challenges like pricing pressure faced by vendors, stringent regulations associated with approval of new vitamin APIs, supply chain disruptions amid pandemic etc. The uncertainties in raw material prices also pose challenge for participants. Establishing manufacturing facilities meeting global quality standards requires large investments and regulatory compliance is a long process which most small players find difficult.

Comments